American Funds AMCAP 529-C (CAFCX)
Nasdaq • Currently up 0.32 (+0.93%) in today's trading session
1 member of Congress has disclosed 1 trade in American Funds AMCAP 529-C (CAFCX) via STOCK Act filings. The most recent disclosure was a sale by Rashida Tlaib on 22 September 2025. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).
American Funds AMCAP 529-C is currently trading at $34.58, positioned at 48% of its 52-week range ($31.31 – $38.15).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
American Funds AMCAP 529-C Price History and Technical Analysis
Congressional Trading Activity for CAFCX
| Rashida Tlaib | 22 Sept 2025 | 20 Aug 2026 | Sale | Stock | $1,001 - $15,000 | N/A |
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about CAFCX
- Which members of Congress have traded CAFCX?
- 1 member of Congress has disclosed 1 trade in American Funds AMCAP 529-C (CAFCX) under the STOCK Act: Rashida Tlaib.
- When was CAFCX most recently disclosed by Congress?
- The most recent CAFCX disclosure was a sale by Rashida Tlaib on 22 September 2025.
- What is the total disclosed congressional trading volume for CAFCX?
- Members of Congress have disclosed approximately $8K in CAFCX sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in CAFCX?
- This CAFCX page updates as soon as new STOCK Act disclosures are filed for American Funds AMCAP 529-C. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track CAFCX in Congress
See when politicians buy or sell this stock